Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Previously Reported [Member]	Revision of Prior Period, Adjustment	Series A Convertible Preferred Stock [Member] Previously Reported [Member]	Series A Convertible Preferred Stock [Member] Revision of Prior Period, Adjustment	Series B Convertible Preferred Stock [Member] Previously Reported [Member]	Series B Convertible Preferred Stock [Member] Revision of Prior Period, Adjustment	Common Stock [Member]	Common Stock [Member] Previously Reported [Member] Old Gemini [Member]	Common Stock [Member] Revision of Prior Period, Adjustment	Common Stock [Member] Revision of Prior Period, Adjustment Old Gemini [Member]	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported [Member]	Additional Paid-in Capital Revision of Prior Period, Adjustment	Retained Earnings	Retained Earnings Previously Reported [Member]
Balance at Dec. 31, 2019	$ (10,432,000)	$ (70,797,000)	$ 60,365,000					$ 1,000	$ 5,000	$ 1,000	$ (5,000)	$ 61,551,000	$ 1,182,000	$ 60,369,000	$ (71,984,000)	$ (71,984,000)
Balance, shares at Dec. 31, 2019				39,722,088	(39,722,088)	9,916,375	(9,916,375)
Balance at Dec. 31, 2019				$ 47,113,000	$ (47,113,000)	$ 13,252,000	$ (13,252,000)
Balance (in Shares) at Dec. 31, 2019								11,979,586	5,313,766	11,979,586	(5,313,766)
Issuance of Series B convertible preferred stock, net of issuance costs of $16								3,242,655
Issuance of Series B convertible preferred stock, net of issuance costs of $16	20,084,000							$ 1,000				20,083,000
Beneficial conversion feature relating to discount on convertible promissory notes	8,177,000											8,177,000
Issuance of common stock upon exercise of stock options	164,000											164,000
Exercised								285,260
Vesting of restricted common stock (in Shares)								57,879
Stock-based compensation expense	983,000											983,000
Net loss	(40,837,000)														(40,837,000)
Balance at Dec. 31, 2020	(21,861,000)	$ 102,310,000	$ 80,449,000					$ 2,000	$ 7,000	$ 2,000	$ (7,000)	90,958,000	$ 10,504,000	$ 80,454,000	(112,821,000)	$ (112,821,000)
Balance at Dec. 31, 2020				39,722,088	(39,722,088)	24,790,938	(24,790,938)
Balance at Dec. 31, 2020				$ 47,113,000	$ (47,113,000)	$ 33,336,000	$ (33,336,000)
Balance (in Shares) at Dec. 31, 2020								15,565,380	6,900,493	15,565,380	(6,900,493)
Issuance of common stock upon Business Combination, net of issuance costs (Note 2)	195,882,000							$ 2,000				195,880,000
Conversion of promissory notes (Note 2)	14,515,000											14,515,000
Conversion of promissory notes (in Shares)								2,341,316
Issuance of common stock upon exercise of warrants (Note 2)	76,000							$ 15,257				76,000
Issuance of common stock upon Business Combination, net of issuance costs (in Shares)								25,041,150
Issuance of common stock upon exercise of stock options	$ 311,000											311,000
Exercised	208,890							209,495
Vesting of restricted common stock (in Shares)								35,561
Stock-based compensation expense	$ 7,787,000											7,787,000
Net loss	(71,869,000)														(71,869,000)
Balance at Dec. 31, 2021	$ 124,841,000							$ 4,000				$ 309,527,000			$ (184,690,000)
Balance (in Shares) at Dec. 31, 2021								43,208,159